UNC Lineberger Comprehensive Cancer Center: Carcinoma trials

The registry lists 13 Carcinoma studies with UNC Lineberger Comprehensive Cancer Center as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 1 1Phase 2 6No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Addressing Cancer-Related Financial Toxicity in North Carolina Oncology Care SettingsCompletedNCT04931251Not applicableResults posted
• PET/MR Characterization of Renal Cell CarcinomasTerminatedNCT04271254Not applicableResults posted
• P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCCCompletedNCT03077243Phase 2Results posted
• De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up StudyCompletedNCT02281955Phase 2Results posted
• Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHNCompletedNCT02124707Phase 2Results posted
• De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell CaCompletedNCT01530997Phase 2Results posted
• Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular CarcinomaCompletedNCT01488487Phase 2Results posted
• Neoadjuvant Pazopanib in Renal Cell CarcinomaCompletedNCT01361113Phase 2Results posted
• HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in MalawiCompletedNCT03160209
• Dose-escalating AZD1775 + Concurrent Radiation + Cisplatin for Intermediate/High Risk HNSCCCompletedNCT02585973Phase 1
• Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)TerminatedNCT02045186Not applicable
• Hybrid PET/MR in the Therapy of Cervical CancerCompletedNCT01759355
• Imaging Correlates of Renal Cell Carcinoma Biological FeaturesCompletedNCT01665703Not applicable